Read an excerpt from The Bethesda Review of Clinical Oncology on Prostate Cancer and then test your knowledge with the questions below.
Read Chapter Now
A 63- year- old male with metastatic castration- resistant prostate cancer (metastatic to the scapula and 3 ribs) is currently being treated with ADT and enzalutamide 160 mg/ daily.
Take the Quiz
A 65- year- old male with mCRPC including metastasis to the pelvis, spine, and ribs has recently started treatment with enzalutamide.
A patient is seeing you in follow- up for his mCPRC including metastasis to the lungs, liver, and spine.